Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$1.58B |
| 2 |
Microsoft
MSFT
|
+$1.31B |
| 3 |
NVIDIA
NVDA
|
+$1.27B |
| 4 |
Amazon
AMZN
|
+$1.1B |
| 5 |
Broadcom
AVGO
|
+$698M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$394M |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
+$354M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$257M |
| 4 |
Palo Alto Networks
PANW
|
+$169M |
| 5 |
SWN
Southwestern Energy Company
SWN
|
+$126M |
Sector Composition
| 1 | Technology | 31.84% |
| 2 | Financials | 13.52% |
| 3 | Consumer Discretionary | 11.33% |
| 4 | Healthcare | 10.12% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Sabre
SABR
$742M
| $33.2M | ﹤0.01% |
9,103,796
+22,537
| +0.2% | +$82.3K |
|
1677
Ingevity
NGVT
$2.14B
| $33.2M | ﹤0.01% |
814,550
-1,111
| -0.1% | -$45.3K |
|
1678
CG Oncology
CGON
$2.53B
| $33.2M | ﹤0.01% |
1,156,670
+78,143
| +7% | +$2.24M |
|
1679
Virtus Investment Partners
VRTS
$1.36B
| $33.1M | ﹤0.01% |
150,069
-1,259
| -0.8% | -$278K |
|
1680
Interface
TILE
$1.67B
| $33.1M | ﹤0.01% |
1,358,926
-13,050
| -1% | -$318K |
|
|
VRE
1681
Veris Residential
VRE
$1.51B
| $33M | ﹤0.01% |
1,984,942
-15,976
| -0.8% | -$266K |
|
1682
AMC Entertainment Holdings
AMC
$1.44B
| $32.9M | ﹤0.01% |
8,271,059
+223,877
| +3% | +$891K |
|
|
ALEX
1683
Alexander & Baldwin
ALEX
$1.37B
| $32.9M | ﹤0.01% |
1,852,782
-23,559
| -1% | -$418K |
|
|
AAT
1684
American Assets Trust
AAT
$1.28B
| $32.8M | ﹤0.01% |
1,247,619
-19,603
| -2% | -$515K |
|
1685
AstraZeneca
AZN
$251B
| $32.7M | ﹤0.01% |
498,831
+5,384
| +1% | +$353K |
|
1686
PureCycle Technologies
PCT
$2.4B
| $32.7M | ﹤0.01% |
3,185,348
+60,903
| +2% | +$624K |
|
1687
Clearway Energy Class C
CWEN
$3.37B
| $32.6M | ﹤0.01% |
1,253,615
-2,777
| -0.2% | -$72.2K |
|
1688
QCR Holdings
QCRH
$1.32B
| $32.5M | ﹤0.01% |
402,487
+1,294
| +0.3% | +$104K |
|
1689
Seadrill
SDRL
$2.09B
| $32.4M | ﹤0.01% |
833,388
+7,041
| +0.9% | +$274K |
|
|
JBGS
1690
JBG SMITH
JBGS
$1.44B
| $32.3M | ﹤0.01% |
2,101,738
-60,104
| -3% | -$924K |
|
|
TGI
1691
DELISTED
Triumph Group
TGI
| $32.2M | ﹤0.01% |
1,723,450
-9,341
| -0.5% | -$174K |
|
1692
Travere Therapeutics
TVTX
$2.23B
| $32.1M | ﹤0.01% |
1,842,301
+111,256
| +6% | +$1.94M |
|
1693
Appian
APPN
$2.33B
| $32.1M | ﹤0.01% |
972,203
+14,710
| +2% | +$485K |
|
1694
Atlas Energy Solutions
AESI
$1.35B
| $32.1M | ﹤0.01% |
1,445,503
-2,837
| -0.2% | -$62.9K |
|
1695
Astrana Health
ASTH
$1.4B
| $32.1M | ﹤0.01% |
1,016,775
-1,243
| -0.1% | -$39.2K |
|
1696
Helen of Troy
HELE
$567M
| $32M | ﹤0.01% |
534,565
-1,318
| -0.2% | -$78.9K |
|
1697
Grid Dynamics Holdings
GDYN
$657M
| $31.9M | ﹤0.01% |
1,433,773
+52,344
| +4% | +$1.16M |
|
1698
Nicolet Bankshares
NIC
$2.01B
| $31.9M | ﹤0.01% |
303,748
+357
| +0.1% | +$37.5K |
|
1699
Viridian Therapeutics
VRDN
$1.6B
| $31.8M | ﹤0.01% |
1,658,980
+165,669
| +11% | +$3.18M |
|
1700
Andersons Inc
ANDE
$1.4B
| $31.7M | ﹤0.01% |
782,716
-2,423
| -0.3% | -$98.2K |
|